- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: Austedo® | SD-809 | SD809 | tetrabenazine D6
deutetrabenazine is an approved drug (FDA (2017))
Compound class: Synthetic organic
Comment: This is an orally available, deuterated analogue of tetrabenazine which can be administered in lower doses and in a simplified dosing regimen. Deutetrabenazine is the first ever deuterated drug to be approved.
In drug discovery, replacing hydrogen atoms in drug compounds with deuterium (deuteration) is a technique employed to inhibit degradation of the drug and its active metabolites. The presence of the deuterium atoms attenuates CYP2D6-driven metabolic breakdown of the compound. This effects an increase in circulating half-lives and improves the duration of therapeutic effect and decreases the dose required to achieve therapeutic concentration .
|The inhibitory ability of deutetrabenazine is likely to be similar to that of its parent compound, tetrabenazine. We have mapped deutetrabenazine to SLC18A2, based on its relationship to the parent molecule, but have been unable to find confirmatory activity data.|
|Selectivity at transporters|
|Key to terms and symbols||Click column headers to sort|